alendronate has been researched along with Hyperlipemia in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parwin, A | 1 |
| Najmi, AK | 1 |
| Ismail, MV | 1 |
| Kaundal, M | 1 |
| Akhtar, M | 1 |
| Zethraeus, N | 1 |
| Ström, O | 1 |
| Borgström, F | 1 |
| Kanis, JA | 1 |
| Jönsson, B | 1 |
2 other studies available for alendronate and Hyperlipemia
| Article | Year |
|---|---|
Protective effects of alendronate in Triton X-100-induced hyperlipidemia in rats.
Topics: Alanine Transaminase; Alendronate; Animals; Aspartate Aminotransferases; Cholesterol, HDL; Cholester | 2019 |
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.
Topics: Aged; Aged, 80 and over; Alendronate; Antihypertensive Agents; Bone Density Conservation Agents; Cos | 2008 |